said Thursday that it promoted Tony Zook as head of U.S. operations for the Anglo-Swedish drug giant.
Zook will succeed David R. Brennan, who recently was chosen as AstraZeneca's CEO after the retirement announcement of
Sir Tom McKillop. All of the executive changes will take place Jan. 1.
Zook, who has more than 20 years of drug industry sales and management experience, is currently AstraZeneca's senior vice president for U.S. commercial operations. Previously, he was vice president for sales.